Elizabeth Fearin
Physician Assistant · McKinney, TXNPI 1447483789
Payments from drug & device makers
Across 316 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Takeda Pharmaceuticals U.S.A., Inc.$867
- Regeneron Healthcare Solutions, Inc.$830
- GSK$660
- Sanofi$306
- Biocryst US Sales Co., LLC$204
- plus $2K from 26 others
What the payments were for
- Food & beverage$6,30599%
- Education$951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $1,631 |
| Takeda Pharmaceuticals U.S.A., Inc. | 47 | $867 |
| Regeneron Healthcare Solutions, Inc. | 56 | $830 |
| GSK | 53 | $660 |
| Sanofi | 16 | $306 |
| Biocryst US Sales Co., LLC | 10 | $204 |
| Octapharma USA, Inc. | 6 | $190 |
| Amgen(2 entities) | 9 | $181 |
| Pfizer | 7 | $159 |
| Grifols USA, LLC | 8 | $151 |
| Pharming Healthcare, Inc. | 5 | $120 |
| Genentech USA, Inc. | 5 | $102 |
| Sanofi-aventis U.S. LLC | 1 | $95 |
| Novartis | 4 | $92 |
| Alk-abello, Inc | 4 | $90 |
| CSL Behring | 4 | $89 |
| Optinose US, Inc. | 4 | $82 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| Kaleo, Inc. | 3 | $67 |
| QOL Medical, LLC | 2 | $49 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $44 |
| Hikma Pharmaceuticals USA | 2 | $43 |
| Merck | 2 | $42 |
| Ionis Pharmaceuticals, Inc. | 1 | $35 |
| Covis Pharma GmbH | 1 | $27 |
| Phadia US Inc. | 1 | $27 |
| Mylan Specialty L.p. | 1 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,399 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $13,227 |
| Ipratropium Bromide | 21 | $664 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $239 |
| Azelastine Hcl | 12 | $220 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $660 | $13,22719 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in McKinney
- Matthew BrunoMcKinney$538K
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.